Precision medicine in COPD: review of mepolizumab for eosinophilic COPD

Precision medicine in COPD: review of mepolizumab for eosinophilic COPD

Bibliographic Details
Main Authors:	Gabriella Long, Jasmine Wall
Format:	Article
Language:	English
Published:	European Respiratory Society 2018-12-01
Series:	Breathe
Online Access:	http://breathe.ersjournals.com/content/14/4/338.full

Similar Items

Mepolizumab for eosinophilic COPD
by: Sciurba, F, et al.
Published: (2018)

Late breaking abstract - Dose-ranging study of mepolizumab in eosinophilic COPD
by: Pavord, I, et al.
Published: (2017)

Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease (COPD): A Meta-Analysis of METREX and METREO Exacerbation Endpoints
by: Bafadhel, M, et al.
Published: (2018)

Glucocorticoids and mepolizumab in eosinophilic asthma.
by: Bel, E, et al.
Published: (2014)

Mepolizumab in refractory eosinophilic asthma.
by: Pavord, I, et al.
Published: (2010)

Seasonality of eosinophilic and non-eosinophilic exacerbations of COPD
by: Barker, R, et al.
Published: (2017)

The significance of eosinophilic inflammation in COPD
by: Cooper, C, et al.
Published: (2017)

Investigating the role of the eosinophil in COPD
by: Camp, JR
Published: (2023)

Characterising non-eosinophilic COPD
by: Hambleton, K, et al.
Published: (2015)

Mepolizumab and exacerbations of refractory eosinophilic asthma.
by: Haldar, P, et al.
Published: (2009)

Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis
by: Wechsler, M, et al.
Published: (2017)

Blood eosinophil depletion with mepolizumab, benralizumab and prednisolone in eosinophilic asthma
by: Moran, AM, et al.
Published: (2020)

Eosinophils in COPD: just another biomarker?
by: Bafadhel, M, et al.
Published: (2017)

Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease (COPD): A Meta-Analysis of METREX and METREO Patient-Reported Outcomes, Response to Therapy and Lung Function
by: Chapman, K, et al.
Published: (2018)

Clinical characteristics of eosinophilic COPD versus COPD patients with a history of asthma
by: Umme Kolsum, et al.
Published: (2017-04-01)

Mepolizumab for eosinophilic chronic obstructive pulmonary disease
by: Pavord, I, et al.
Published: (2017)

Mepolizumab, quality of life, and severe eosinophilic asthma.
by: Pavord, I
Published: (2017)

Mepolizumab treatment in patients with severe eosinophilic asthma.
by: Ortega, H, et al.
Published: (2014)

Clinical usefulness of mepolizumab in severe eosinophilic asthma
by: Menzella F, et al.
Published: (2016-06-01)

Blood eosinophil levels as a biomarker in COPD
by: Brusselle, G, et al.
Published: (2018)

Eosinophils in COPD: why should I care?
by: Frederico Leon Arrabal Fernandes

Pulmonary hypertension in eosinophilic versus noneosinophilic COPD
by: Bashar N. Alzghoul, et al.
Published: (2021-03-01)

Eosinophils in COPD: why should I care?
by: Frederico Leon Arrabal Fernandes
Published: (2016-08-01)

Eicosanoids and Eosinophilic Inflammation of Airways in Stable COPD
by: Celejewska-Wójcik N, et al.
Published: (2021-05-01)

Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma.
by: Bel, E, et al.
Published: (2014)

Mepolizumab in the treatment of eosinophilic chronic obstructive pulmonary disease
by: Mkorombindo T, et al.
Published: (2019-08-01)

Efficacy of add-on mepolizumab in adolescents with severe eosinophilic asthma
by: Steven W. Yancey, et al.
Published: (2019-09-01)

Blood Eosinophils and outcomes in severe hospitalized exacerbations of COPD
by: Bafadhel, M, et al.
Published: (2016)

Investigating blood eosinophil count thresholds in patients with COPD
by: Russell, R, et al.
Published: (2018)

Blood eosinophil count and exacerbation risk in patients with COPD.
by: Kerkhof, M, et al.
Published: (2017)

Variability of blood eosinophil count and prognosis of COPD exacerbations
by: Sandra Martínez-Gestoso, et al.
Published: (2021-01-01)

Blood eosinophil count as a prognostic biomarker in COPD
by: Oh YM, et al.
Published: (2018-10-01)

Burden of disease associated with a COPD eosinophilic phenotype
by: Ortega H, et al.
Published: (2018-08-01)

Upper airway symptoms associate with the eosinophilic phenotype of COPD
by: Nicolai Obling, et al.
Published: (2021-08-01)

Blood and sputum eosinophils in COPD; relationship with bacterial load
by: Umme Kolsum, et al.
Published: (2017-05-01)

Clinical implications of blood eosinophil count in patients with non-asthma–COPD overlap syndrome COPD
by: Song JH, et al.
Published: (2017-08-01)

Real-life efficacy and safety of mepolizumab for eosinophilic granulomatosis with polyangiitis
by: Giuseppe A. Ramirez, et al.
Published: (2022-12-01)

Efficacy of mepolizumab for patients with severe asthma and eosinophilic chronic rhinosinusitis
by: Takanori Numata, et al.
Published: (2019-10-01)

Efficacy and safety of mepolizumab in Japanese patients with severe eosinophilic asthma
by: Terufumi Shimoda, et al.
Published: (2017-07-01)

Patient profiles and clinical utility of mepolizumab in severe eosinophilic asthma
by: Haldar P
Published: (2017-06-01)